tirzepatide drug shortage list FDA reconsidering its decision to take off its GLP-1 Drugs: FDA Removes Semaglutide

Adding injection site helps with rotation

The Trade-Off Conversation For many people considering GLP-1 medications, the potential for facial changes represents one factor in a larger decision

"It makes sense because obesity is a chronic disease and like most of our other chronic diseases, like high blood pressure, we wouldn't imagine stopping high blood pressure medications once blood pressure is at target." Heather White knows the challenges of excess weight and its medical consequences first hand

After years of pain and discomfort, missing out on events, experiencing social anxiety and depression I have finally found myself again